Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2018.04.015
Abstract: Gene expression profiling has had a considerable impact on our understanding ofbreastcancer biology. Duringthelast decade, 4 intrinsic molecular subtypes of breast cancer (Luminal A, Luminal B, HER2-enriched [HER2-E] and Basal-like) have been identified and intensively… read more here.
Keywords: clinical implications; breast cancer; non luminal; cancer ... See more keywords
The value of multiparametric MRI-based combined intratumoral and peritumoral radiomics in differentiating luminal and non-luminal molecular subtypes of breast cancer: a multicenter study
Sign Up to like & getrecommendations! Published in 2025 at "Gland Surgery"
DOI: 10.21037/gs-2025-83
Abstract: Background Breast cancer remains the predominant contributor to global cancer-related morbidity and mortality in women. Luminal subtypes, accounting for approximately 70% of cases, demonstrate favorable prognoses through endocrine-targeted therapeutic regimens owing to hormone receptor positivity.… read more here.
Keywords: cancer; breast cancer; luminal non; intratumoral peritumoral ... See more keywords
Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1140514
Abstract: Background The goal of this study was to develop and validate a radiomics signature based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) preoperatively differentiating luminal and non-luminal molecular subtypes in patients with invasive breast cancer.… read more here.
Keywords: molecular subtypes; radiomics signature; breast cancer; non luminal ... See more keywords
Development and validation of an ultrasound-based radiomics nomogram for predicting the luminal from non-luminal type in patients with breast carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.993466
Abstract: Introduction The molecular subtype plays a significant role in breast carcinoma (BC), which is the main indicator to guide treatment and is closely associated with prognosis. The aim of this study was to investigate the… read more here.
Keywords: luminal non; rad score; non luminal; luminal type ... See more keywords
Cross-attention multi-branch CNN using DCE-MRI to classify breast cancer molecular subtypes
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1107850
Abstract: Purpose The aim of this study is to improve the accuracy of classifying luminal or non-luminal subtypes of breast cancer by using computer algorithms based on DCE-MRI, and to validate the diagnostic efficacy of the… read more here.
Keywords: breast; dce mri; breast cancer; non luminal ... See more keywords
Application of DCE-MRI radiomics and heterogeneity analysis in predicting luminal and non-luminal subtypes of breast cancer
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2025.1523507
Abstract: Purpose The aim of this study was to explore the application value of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) radiomics and heterogeneity analysis in the differentiation of molecular subtypes of luminal and non-luminal breast cancer.… read more here.
Keywords: breast cancer; luminal non; heterogeneity; non luminal ... See more keywords